Results 331 to 340 of about 933,327 (380)

From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants

Current Opinion in Lipidology, 2019
Purpose of review The validity of HDL-cholesterol (HDL-C) elevation as a therapeutic target has been questioned, in comparison to enhancing HDL functionality. Cholesterol efflux capacity (CEC) is an in-vitro assay that measures the ability of an individual's HDL to promote cholesterol efflux from cholesterol donor cells such as
David, Rhainds, Jean-Claude, Tardif
openaire   +3 more sources

Monocyte‐to‐HDL‐cholesterol ratio as a prognostic marker in cardiovascular diseases

Journal of Cellular Physiology, 2018
Inflammation and lipid accumulation are two basic hallmarks of atherosclerosis as a chronic disease. Inflammation not only is a local response but can also be considered as a systemic process followed by an elevation of inflammatory mediators.
S. Ganjali   +6 more
semanticscholar   +1 more source

Serum cholesterol and HDL cholesterol in childhood

Irish Journal of Medical Science, 1981
Serum concentrations of total cholesterol and of HDL cholesterol have been measured in 170 Irish children, aged 1–12 years, attending hospital for conditions other than hyperlipidaemia. There were no significant differences between the sexes, or between fasting and non-fasting samples for either estimation.
D A, Kelly   +4 more
openaire   +2 more sources

Cholesterol, High Density Lipoprotein‐Cholesterol (HDL) and Cholesterol/HDL‐ratio Versus Arterial Blood Pressure.

Acta Medica Scandinavica, 1981
Abstract: In a cardiovascular survey of 928 men and women aged exactly 30, 40, 50 & 60 years, a correlation between serum cholesterol, cholesterol/HDL‐ratio and arterial blood pressure was found. This correlation was indirectly caused by mutual correlations to relative weight and age as a final result found after multiple rank correlation analysis
E, Agner   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy